| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 343.108 | 359.810 | 435.739 | 468.424 | 429.052 | 496.858 | 523.715 | 652.205 | 806.452 | 881.074 |
| Total Income - EUR | 345.638 | 363.046 | 437.856 | 469.100 | 429.052 | 497.066 | 523.727 | 656.433 | 806.466 | 884.289 |
| Total Expenses - EUR | 323.772 | 350.289 | 412.407 | 453.402 | 418.389 | 474.296 | 504.350 | 616.133 | 759.233 | 862.994 |
| Gross Profit/Loss - EUR | 21.867 | 12.756 | 25.449 | 15.698 | 10.663 | 22.770 | 19.377 | 40.300 | 47.233 | 21.295 |
| Net Profit/Loss - EUR | 17.648 | 10.050 | 20.825 | 11.007 | 6.367 | 18.528 | 14.136 | 33.687 | 41.533 | 20.726 |
| Employees | 5 | 5 | 7 | 8 | 7 | 8 | 9 | 8 | 6 | 0 |
Check the financial reports for the company - Farmacris Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.371 | 21.969 | 29.873 | 24.675 | 17.925 | 11.433 | 8.560 | 10.861 | 21.046 | 20.982 |
| Current Assets | 192.994 | 275.737 | 257.493 | 196.054 | 200.127 | 239.241 | 286.396 | 235.470 | 302.761 | 311.537 |
| Inventories | 51.406 | 65.364 | 65.507 | 56.022 | 47.949 | 55.528 | 75.043 | 105.799 | 115.527 | 191.524 |
| Receivables | 47.720 | 144.424 | 143.814 | 137.394 | 130.353 | 137.746 | 153.854 | 87.069 | 146.469 | 112.174 |
| Cash | 93.868 | 65.950 | 48.172 | 2.638 | 21.826 | 45.967 | 57.498 | 42.601 | 40.764 | 7.839 |
| Shareholders Funds | 123.719 | 38.748 | 54.308 | 41.698 | 47.258 | 64.890 | 27.050 | 34.459 | 41.582 | 20.774 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 94.647 | 258.959 | 233.058 | 179.030 | 170.795 | 185.784 | 267.906 | 211.872 | 282.225 | 311.746 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacris Life Srl